Carregant...
Does the development of new medicinal products in the European Union address global and regional health concerns?
BACKGROUND: Since 1995, approval for many new medicinal products has been obtained through a centralized procedure in the European Union. In recent years, the use of summary measures of population health has become widespread. We investigated whether efforts to develop innovative medicines are focus...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3017015/ https://ncbi.nlm.nih.gov/pubmed/21172012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1478-7954-8-34 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|